S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:TLGT

Teligent Stock Forecast, Price & News

$0.82
-0.09 (-9.85 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.82
Now: $0.82
$0.92
50-Day Range
$0.88
MA: $1.07
$1.36
52-Week Range
$0.46
Now: $0.82
$6.46
Volume4.09 million shs
Average Volume5.72 million shs
Market Capitalization$17.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.79
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The company's topical semi-solid and liquid products are used in various applications that range from cosmetics and cosmeceuticals; and the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. It sells its products through national chain drug stores, drug wholesalers, distributors, and group purchasing organizations. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Teligent logo

Headlines

Form 424B5 Teligent, Inc. - StreetInsider.com
January 28, 2021 |  streetinsider.com
Teligent, Inc. (TLGT)
December 17, 2020 |  finance.yahoo.com
Looking Into Teligent's Return On Capital Employed
October 22, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLGT
CUSIPN/A
Phone856-697-1441
Employees252
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$65.90 million
Book Value($0.99) per share

Profitability

Net Income$-25,120,000.00

Miscellaneous

Market Cap$17.93 million
Next Earnings Date4/14/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.20 out of 5 stars

Medical Sector

850th out of 1,968 stocks

Pharmaceutical Preparations Industry

412th out of 772 stocks

Analyst Opinion: 3.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.82
-0.09 (-9.85 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLGT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Teligent (NASDAQ:TLGT) Frequently Asked Questions

Is Teligent a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Teligent stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLGT, but not buy additional shares or sell existing shares.
View analyst ratings for Teligent
or view top-rated stocks.

What stocks does MarketBeat like better than Teligent?

Wall Street analysts have given Teligent a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Teligent wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Teligent?

Teligent saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 380,600 shares, an increase of 249.2% from the January 28th total of 109,000 shares. Based on an average daily trading volume, of 6,920,000 shares, the short-interest ratio is presently 0.1 days. Approximately 0.7% of the shares of the company are sold short.
View Teligent's Short Interest
.

When is Teligent's next earnings date?

Teligent is scheduled to release its next quarterly earnings announcement on Wednesday, April 14th 2021.
View our earnings forecast for Teligent
.

How were Teligent's earnings last quarter?

Teligent, Inc. (NASDAQ:TLGT) posted its quarterly earnings data on Wednesday, December, 30th. The company reported ($2.09) EPS for the quarter, missing the Zacks' consensus estimate of ($1.48) by $0.61. The business had revenue of $14.34 million for the quarter.
View Teligent's earnings history
.

How has Teligent's stock been impacted by COVID-19 (Coronavirus)?

Teligent's stock was trading at $3.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TLGT stock has decreased by 74.6% and is now trading at $0.8240.
View which stocks have been most impacted by COVID-19
.

When did Teligent's stock split? How did Teligent's stock split work?

Teligent's stock reverse split on Thursday, May 28th 2020. The 1-10 reverse split was announced on Wednesday, May 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 27th 2020. An investor that had 100 shares of Teligent stock prior to the reverse split would have 10 shares after the split.

What guidance has Teligent issued on next quarter's earnings?

Teligent updated its fourth quarter 2020 IntraDay earnings guidance on Thursday, December, 31st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $11-12.5 million, compared to the consensus revenue estimate of $15.45 million.

What price target have analysts set for TLGT?

1 Wall Street analysts have issued 12 month target prices for Teligent's stock. Their forecasts range from $2.00 to $2.00. On average, they expect Teligent's share price to reach $2.00 in the next year. This suggests a possible upside of 142.7% from the stock's current price.
View analysts' price targets for Teligent
or view top-rated stocks among Wall Street analysts.

Who are Teligent's key executives?

Teligent's management team includes the following people:
  • Mr. Timothy B. Sawyer, Pres, CEO & Director (Age 56)
  • Mr. Antonio Di Nicola, GM & VP of Operations
  • Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 52, Pay $186.63k)
  • Mr. Philip K. Yachmetz, Chief Legal Officer & Corp. Sec. (Age 64)
  • Mr. Mark Mantel, VP of Sales & Marketing and GM of Canada
  • Ms. Justine Kostka, Assistant Controller (Age 67)
  • Dr. Subhash Saxena, Technical Consultant and Member of Scientific Advisory Board

What is Tim Sawyer's approval rating as Teligent's CEO?

2 employees have rated Teligent CEO Tim Sawyer on Glassdoor.com. Tim Sawyer has an approval rating of 100% among Teligent's employees. This puts Tim Sawyer in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Teligent's key competitors?

What other stocks do shareholders of Teligent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teligent investors own include Novavax (NVAX), ChemoCentryx (CCXI), Voyager Therapeutics (VYGR), AbbVie (ABBV), General Electric (GE), Biocept (BIOC), Lannett (LCI), Pfizer (PFE), Selecta Biosciences (SELB) and VBI Vaccines (VBIV).

What is Teligent's stock symbol?

Teligent trades on the NASDAQ under the ticker symbol "TLGT."

Who are Teligent's major shareholders?

Teligent's stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.91%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, James C Gale, Jason Grenfell-Gardner and Sciences Opportunities Fu Life.
View institutional ownership trends for Teligent
.

Which institutional investors are buying Teligent stock?

TLGT stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. Company insiders that have bought Teligent stock in the last two years include Bhaskar Chaudhuri, Carole Ben-Maimon, James C Gale, and Jason Grenfell-Gardner.
View insider buying and selling activity for Teligent
or or view top insider-buying stocks.

How do I buy shares of Teligent?

Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teligent's stock price today?

One share of TLGT stock can currently be purchased for approximately $0.82.

How much money does Teligent make?

Teligent has a market capitalization of $17.93 million and generates $65.90 million in revenue each year.

How many employees does Teligent have?

Teligent employs 252 workers across the globe.

What is Teligent's official website?

The official website for Teligent is www.teligent.com.

Where are Teligent's headquarters?

Teligent is headquartered at 105 LINCOLN AVENUE, BUENA NJ, 08310.

How can I contact Teligent?

Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.